Urine test may detect kidney cancer early
the ONA take:
According to a recent study published in JAMA Oncology, researchers at Washington University School of Medicine in St. Louis, Missouri, have developed a noninvasive urine test that screens for kidney cancer.
For the study of the screening method, researchers analyzed urine samples from 720 patients were about to undergo an abdominal CT scan for reasons other than suspicion of kidney cancer, 80 healthy people, and 19 patients previously diagnosed with cancer. The test measured levels of two proteins biomarkers in the urine.
Results showed that none of the 80 healthy people had increased levels of either biomarker and all of the 19 patients with kidney cancer had elevated levels of both. In addition, three of the 720 patients who underwent an abdominal CT scan had increased levels of both proteins; two were confirmed to have kidney cancer.
Ultimately, the protein biomarkers were over 95% accurate in identifying early-stage kidney cancer and the test did not result in any false-positive caused by non-cancerous kidney disease.
Researchers developed a noninvasive urine test that screens for kidney cancer.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|